Żmudzka, E.; Lustyk, K.; Głuch-Lutwin, M.; Wolak, M.; Jaśkowska, J.; Kołaczkowski, M.; Sapa, J.; Pytka, K.
Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice. Pharmaceuticals 2023, 16, 175.
https://doi.org/10.3390/ph16020175
AMA Style
Żmudzka E, Lustyk K, Głuch-Lutwin M, Wolak M, Jaśkowska J, Kołaczkowski M, Sapa J, Pytka K.
Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice. Pharmaceuticals. 2023; 16(2):175.
https://doi.org/10.3390/ph16020175
Chicago/Turabian Style
Żmudzka, Elżbieta, Klaudia Lustyk, Monika Głuch-Lutwin, Małgorzata Wolak, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, and Karolina Pytka.
2023. "Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice" Pharmaceuticals 16, no. 2: 175.
https://doi.org/10.3390/ph16020175
APA Style
Żmudzka, E., Lustyk, K., Głuch-Lutwin, M., Wolak, M., Jaśkowska, J., Kołaczkowski, M., Sapa, J., & Pytka, K.
(2023). Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice. Pharmaceuticals, 16(2), 175.
https://doi.org/10.3390/ph16020175